Literature DB >> 29054853

British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).

Charles S Haworth1, John Banks2, Toby Capstick3, Andrew J Fisher4, Thomas Gorsuch5, Ian F Laurenson6, Andrew Leitch7, Michael R Loebinger8, Heather J Milburn9, Mark Nightingale10, Peter Ormerod11, Delane Shingadia12, David Smith13, Nuala Whitehead14, Robert Wilson8, R Andres Floto1,15.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29054853     DOI： 10.1136/thoraxjnl-2017-210927

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  145 in total

1.  β-Lactam Combinations That Exhibit Synergy against Mycobacteroides abscessus Clinical Isolates.

Authors:  Elizabeth Story-Roller; Christos Galanis; Gyanu Lamichhane
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

2.  Antimicrobial Susceptibility of Clinical and Environmental Mycobacterium chimaera Isolates.

Authors:  Simone Mok; Margaret M Hannan; Lars Nölke; Patrick Stapleton; Niamh O'Sullivan; Philip Murphy; Anne Marie McLaughlin; Eleanor McNamara; Margaret M Fitzgibbon; Thomas R Rogers
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

3.  Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease.

Authors:  Seong Mi Moon; In Young Yoo; Hee Jae Huh; Nam Yong Lee; Byung Woo Jhun
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

4.  Differential In Vitro Activities of Individual Drugs and Bedaquiline-Rifabutin Combinations against Actively Multiplying and Nutrient-Starved Mycobacterium abscessus.

Authors:  Jin Lee; Nicole Ammerman; Anusha Agarwal; Maram Naji; Si-Yang Li; Eric Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

5.  Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven?

Authors:  Simone K Visser; Peter T P Bye; Greg J Fox; Lucy D Burr; Anne B Chang; Chien-Li Holmes-Liew; Paul King; Peter G Middleton; Graeme P Maguire; Daniel Smith; Rachel M Thomson; Enna Stroil-Salama; Warwick J Britton; Lucy C Morgan
Journal:  Lung       Date:  2019-11-05       Impact factor: 2.584

6.  Comparison of a Novel Regimen of Rifapentine, Tedizolid, and Minocycline with Standard Regimens for Treatment of Pulmonary Mycobacterium kansasii.

Authors:  Moti Chapagain; Tawanda Gumbo; Scott K Heysell; Shashikant Srivastava
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

7.  In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates.

Authors:  Dae Hun Kim; Byung Woo Jhun; Seong Mi Moon; Su-Young Kim; Kyeongman Jeon; O Jung Kwon; Hee Jae Huh; Nam Yong Lee; Sung Jae Shin; Charles L Daley; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

8.  Stepwise pathogenic evolution of Mycobacterium abscessus.

Authors:  Josephine M Bryant; Karen P Brown; Sophie Burbaud; Isobel Everall; Juan M Belardinelli; Daniela Rodriguez-Rincon; Dorothy M Grogono; Chelsea M Peterson; Deepshikha Verma; Ieuan E Evans; Christopher Ruis; Aaron Weimann; Divya Arora; Sony Malhotra; Bridget Bannerman; Charlotte Passemar; Kerra Templeton; Gordon MacGregor; Kasim Jiwa; Andrew J Fisher; Tom L Blundell; Diane J Ordway; Mary Jackson; Julian Parkhill; R Andres Floto
Journal:  Science       Date:  2021-04-30       Impact factor: 47.728

9.  Efficacy of Bedaquiline, Alone or in Combination with Imipenem, against Mycobacterium abscessus in C3HeB/FeJ Mice.

Authors:  Vincent Le Moigne; Clément Raynaud; Flavie Moreau; Christian Dupont; Jérôme Nigou; Olivier Neyrolles; Laurent Kremer; Jean-Louis Herrmann
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

10.  Drug susceptibility distributions of Mycobacterium chimaera and other non-tuberculous mycobacteria.

Authors:  Bettina Schulthess; Daniel Schäfle; Nicole Kälin; Tamara Widmer; Peter Sander
Journal:  Antimicrob Agents Chemother       Date:  2021-02-22       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.